Get started
Author

G. Floris

Observed names: Floris G, Floris, G., G Floris
OpenAlex ID: A5068614463
Algorithms for molecular testing in solid tumours
2019 · A. Hébrant, Martin Lammens, et al. · Ghent University Academic Bibliography (Ghent University) · 2
Abstract PS4-12-24: Risk and Pattern of Relapse in Triple-Negative Breast Cancer with Pathological Complete Response after Neoadjuvant Treatment: Updated Results from the European GAMBIT Real-world Study
2026 · M. Dieci, T. Foukakis, et al. · Clinical Cancer Research · 1
2O Integrating tumor infiltrating lymphocytes and nodal status for risk stratification in patients (pts) with triple-negative breast cancer (TNBC) and pathological complete response (pCR) after neoadjuvant treatment (NAT)
2025 · D. Massa, S.O. Giacchetti, et al. · ESMO Open · 1
PDF
198P Multifocality in patients with primary invasive lobular breast cancer (ILC): Association with clinicopathological variables and immunohistochemical marker discrepancies
2026 · T. Van Assche, K. Van Baelen, et al. · ESMO Open
694P Determinants of early versus late distant recurrences in stage I–III invasive lobular carcinoma
2026 · K. Van Baelen, G. Biganzoli, et al. · ESMO Open
PDF
458P Comparing clinical profiles and survival between patients with non-metastatic (M0) and de novo metastatic lobular breast cancer (dnILC)
2026 · K. Borremans, G. Biganzoli, et al. · ESMO Open
292P Distant recurrences in stage II Invasive lobular carcinoma: Clinical implications for adjuvant CDK4/6 Inhibitor use
2026 · K. Van Baelen, G. Biganzoli, et al. · ESMO Open
76P Inflammatory lobular breast cancer (IBC ILC) is a rare entity with aggressive behavior: Insights from a retrospective cohort
2026 · K. Borremans, H.L. Nguyen, et al. · ESMO Open
PDF
Abstract PD9-11: The association of breast density with clinicopathological characteristics and survival in patients with early stage ER+ HER2- lobular breast cancer
2026 · J. Van Cauwenberge, H. Nguyen, et al. · Clinical Cancer Research
PS4-05-15: Immunohistochemical characterization of the tumor cells present in four body fluids from patients with metastatic breast cancer in the context of the UPTIDER program
2026 · C. Carette, G. Zels, et al. · Clinical Cancer Research
Abstract PS3-09-07: Adherence to adjuvant endocrine treatment in women 36-56yrs with a hormone receptor-positive breast cancer: Patient compliance and impact on prognosis
2026 · M. Van Houdt, L. De Nys, et al. · Clinical Cancer Research
Abstract PS2-06-16: Two cohorts of young women (<41y at diagnosis) with invasive breast cancer: Single center data on how demographics, tumor characteristics, therapies and 5-year survival differ when treated 2000-2005 and 2014-2019
2026 · B. Goots, A. Laenen, et al. · Clinical Cancer Research
Abstract PS5-08-27: Single arm phase II study with abemaciclib and bicalutamide in locoregionally advanced inoperable or metastatic androgen receptor-positive triple-negative breast cancer (ABBICAR)
2026 · K. Borremans, A. Laenen, et al. · Clinical Cancer Research
Abstract PS3-09-20: Not all pN1 ER-pos HER2-neg breast cancers are equal: why careful patient selection is key for adjuvant ribociclib
2026 · B. Salaets, A. Deblander, et al. · Clinical Cancer Research
Abstract PS2-08-08: Comparison of anthropometric, systemic and mammary adiposity measures in patients with breast cancer
2026 · J. Van Cauwenberge, I. Bachir, et al. · Clinical Cancer Research
Abstract PS5-10-11: Metachrone contralateral breast cancers: Differences in detection mode, Nottingham Prognostic Index, ER, PR and HER2
2026 · E. Bloemen, A. Laenen, et al. · Clinical Cancer Research
60P Expression of antibody-drug conjugate targets in metastatic breast cancer
2024 · K. Borremans, A. Pabba, et al. · ESMO Open
PDF
Serum methylmalonic acid concentrations at breast cancer diagnosis are not associated with distant metastases
2022 · Q. Wu, S. Hatse, et al. · European Journal of Cancer
Abstract P3-04-03: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients
2018 · L Jongen, G Floris, et al. · Cancer Research
Works count: 21
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type